Signing of 1935 US-Brazil FTA

Americas Act Addresses Key Failure of Past Trade Deals

U.S. Senator Bill Cassidy (R-LA) has released a discussion draft of a sweeping, ambitious bill titled the “Americas Act”. The bill states its aim to “establish a regional trade, investment, and people-to-people partnership of countries in the Western Hemisphere”. But unlike every other U.S. trade agreement in the last century, the Americas Act actually undertakes…

It’s Productivism, Not Protectionism

Global Rebalancing Will Lead to Global Prosperity European leaders and the media are up in arms over recent U.S. policy decisions to support the reshoring of American industry. The export ban on advanced U.S. semiconductor equipment, the tax credits for renewable energy equipment made in the U.S., and especially the support for American-made electric vehicles…

Duty-Free Steel Imports from Mexico Surge Beyond Agreed Upon Levels

Key Points Steel imports from Mexico have surged over the past several years. U.S. steel imports from Mexico have risen by 141% over historic levels, with some subcategories of imports tripling and quadrupling, despite a 2019 U.S.-Mexico agreement to maintain steel imports at past levels. The surge in steel imports in Mexican steel conduit, used…

Tariff schedule

Repealing China’s Most Favored Nation Status: A Guide

By Charles Benoit, CPA Trade Counsel In December, the U.S.-China Commission, a group created by Congress to advise on managing the bilateral relationship, formally recommended that China lose its Most-Favored Nation (MFN) tariff status. Referencing the decision to grant China permanent MFN status in 2001, Speaker McCarthy said in remarks on the House floor yesterday…

Skyrocketing Pharmaceutical Imports to the U.S. Endanger National Security

Key Points U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge. India and China are increasingly the leading U.S. source for generic pharmaceuticals, which account for 90% of all prescriptions written in the U.S. In 2021, China was the leading source for U.S. pharmaceutical…